Triad Isotopes PET Drug Earns FDA Approval

The U.S. Food and Drug Administration (FDA) approves Triad Isotopes' Abbreviated New Drug Application (ANDA) for Fludeoxyglucose F18 (18F FDG) which is indicated for positron emmission tomography (PET) imaging in Oncology, Cardiology and Neurology. For more information, please read the full article below.